Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Neuroimaging study of panic disorder according to escitalopram treatment

Trial Profile

Neuroimaging study of panic disorder according to escitalopram treatment

Completed
Phase of Trial: Phase II

Latest Information Update: 22 Jul 2011

At a glance

  • Drugs Escitalopram (Primary)
  • Indications Panic disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 Jul 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 22 Jul 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 22 Jul 2011 Actual trial end date (Dec 2008) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top